CIDP Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)
Condition:   Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Intervention:   Drug: Rozanolixizumab Sponsor:   UCB Biopharma SRL Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2021 Category: Research Source Type: clinical trials

Biorepository and Registry for Plasma Exchange Patients
Conditions:   Antibody-mediated Rejection;   NMO Spectrum Disorder;   TTP;   CIDP Intervention:   Sponsor:   Charles M Knudson Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2021 Category: Research Source Type: clinical trials